American Optometric Association

04/02/2026

As GLP-1 medications continue to dominate national health conversations, the AOA is ensuring that eye health is part of that dialogue. With an estimated 12% of U.S. adults reporting they have used a GLP-1, the AOA’s Eye Deserve More campaign is leading a public awareness effort to educate Americans about the rare but serious vision-related risks associated with these medications—and the critical role doctors of optometry play in protecting patients’ overall health.

Learn more and download a new member toolkit to educate your patients and communities about GLP-1s and eye health.

Amid growing GLP-1 use, the AOA’s national awareness campaign, Eye Deserve More, educates Americans on potential vision risks and reinforces the importance of comprehensive eye exams with a doctor of optometry.

04/01/2026

You’d be a fool to miss this. The next AOA OD Talks Webinar Series: Myopia Myths Debunked will feature an evidence-based discussion that cuts through the noise surrounding myopia management.

Enroll here or scan the QR code: https://go.aoa.org/4bHW6XJ

03/31/2026

Reminder! If you were required to participate in the Medicare Merit-Based Incentive Program (MIPS) in 2025, today is the last day to attest! Looking ahead, to prepare for MIPS success in 2026, visit AOA's Eyelearn to access updated resources: https://bit.ly/4bJ2SMR

An high-level overview of MIPS

03/30/2026

Tomorrow is the last day to get the lowest registration rates for ! Get registered now: https://ow.ly/HFSv50Y4rhy

Tomorrow is the last day to get the lowest registration rates for ! Attendees can expect:

🌵200+ CE and professional development

🌵300 credit hours

🌵90 hours of integrated education

🌵15+ hands-on workshops

What are you waiting for? Register now: https://ow.ly/HFSv50Y4rhy

03/27/2026

Clinical tools and insights from members of the AOA’s Vision Rehabilitation Committee.

Members of the AOA’s Vision Rehabilitation Committee share clinical tools and insights for brain injury and vision.

03/26/2026

Taking active steps to safeguard public health and patient safety, the AOA is calling for prompt federal enforcement action, submitting a formal complaint to the U.S. Food and Drug Administration focused on the Eyebot vision testing kiosk.

Detailed legal complaint documents patient safety, health and product claim concerns—and seeks immediate federal agency enforcement action.

03/25/2026

Although many ‘not-a-doctor’ bills have died in committee or failed to pass both chambers, constant vigilance and ongoing relationship-building are necessary to combat future attacks.

AOA affiliates continue to fight against restrictive legislation.

03/24/2026

A change to the HIPAA privacy rule relating to substance use disorder records has prompted worries about compliance among doctors of optometry. The good news: the change probably doesn’t require immediate changes in your practice.

Most doctors of optometry can wait to update their Notice of Privacy Practices with AOA’s updated form.

03/23/2026

Kansas is the fifteenth state to authorize doctors of optometry to use ophthalmic lasers.

Kansas becomes the fifteenth state to authorize doctors of optometry to use ophthalmic lasers.

03/19/2026

03/19/2026

This week, more than 375 of optometry’s advocates assembled in Washington, D.C., to advance the AOA’s federal priorities with the nation’s health policy leaders as part of AOA on Capitol Hill | AOA Federal Keyperson Summit.

More than 375 of optometry’s advocates rallied on Capitol Hill for expanded eye care access and patient protections.

03/18/2026

AOA board members and staff, led by AOA President Jacquie M. Bowen, O.D., officially opened AOA's Capitol Hill office in between AOA on Capitol Hill meetings with legislators advocating for optometry's essential and expanding role in health care. Doubling down on optometry's presence in the nation's capital, optometry's advocates have a home base to connect with legislators and advance optometry's priorities, including physician-level recognition and reimbursement and coverage fairness.